Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,865 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C, Buendía P, Cuadrado MJ, Siendones E, Aguirre MA, Barbarroja N, Montiel-Duarte C, Torres A, Khamashta M, Velasco F. López-Pedrera C, et al. Among authors: torres a. Arthritis Rheum. 2006 Jan;54(1):301-11. doi: 10.1002/art.21549. Arthritis Rheum. 2006. PMID: 16385547 Free article.
Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
Barbarroja N, Torres LA, Luque MJ, Carretero RM, Valverde-Estepa A, Lopez-Sanchez LM, Rodriguez-Ariza A, Velasco F, Torres A, López-Pedrera C. Barbarroja N, et al. Among authors: torres a, torres la. Exp Hematol. 2009 Jun;37(6):679-91. doi: 10.1016/j.exphem.2009.03.001. Exp Hematol. 2009. PMID: 19463770 Free article.
Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors.
Siendones E, Barbarroja N, Torres LA, Buendía P, Velasco F, Dorado G, Torres A, López-Pedrera C. Siendones E, et al. Among authors: torres a, torres la. Hematol Oncol. 2007 Mar;25(1):30-7. doi: 10.1002/hon.805. Hematol Oncol. 2007. PMID: 17128418
Fechtner's syndrome.
Velasco F, Espinosa M, Torres A. Velasco F, et al. Among authors: torres a. Haematologica. 2000 Sep;85(9):988. Haematologica. 2000. PMID: 10980641 No abstract available.
4,865 results